+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years +
All Genders
ID05558605

Artificial Intelligence-Guided Echocardiography to Improve Heart Failure and Valve Disease Management in Rural and Remote Patients

Led by Baker Heart and Diabetes Institute · Updated on 2026-09-30

612

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Heart failure and valvular heart disease are significant health concerns in rural and remote Australia, partly due to an aging population and higher rates of rheumatic heart disease in Aboriginal communities. These conditions often go undiagnosed until later stages, leading to avoidable hospital admissions and healthcare costs. This trial evaluates the use of artificial intelligence AI-based echocardiography to improve triage and management for patients with known or suspected heart disease in these areas. The study is a world-first randomized controlled trial aiming to detect early stages of heart failure and valvular disease, select appropriate management, and reduce hospital admissions while preserving quality of life. Participants will be randomly assigned to one of two groups. One group will receive AI-guided echocardiography performed by non-experts using a desktop echo machine with AI software at remote clinics images will be securely uploaded to the cloud for expert measurement and interpretation. The other group will receive standard echocardiography performed by sonographers at referral hospitals or visiting teams, which usually involves delays. The study involves up to 1200 individuals aged 45 or older with cardiovascular risk factors, recruited from multiple rural and remote locations and in partnership with Aboriginal communities. During the study, participants will undergo echocardiography according to their assigned group, with images analyzed centrally for diagnosis of cardiac dysfunction or valve disease over 12 months. Researchers will monitor management decisions and health outcomes related to heart failure and valvular disease. The primary outcome is the diagnosis of cardiac dysfunction or valve disease within a year. The study includes assessments through cloud-based image storage and expert review, aiming to improve access to this essential diagnostic test and support early intervention in rural and remote populations.

CONDITIONS

Brief Title

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Research Team

T

Tom Marwick, MBBS, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here